A DARPA-Funded Implantable Biochip To Detect COVID-19 Could Hit Markets By 2021

Updated: Nov 17, 2020

We’re doing a twofer on the hydrogel biosensor that may be used in an upcoming Covid vaccine and very much more.

By Pam Barker | Director of TLB Europe Reloaded Project September 19, 2020

Read the original article here: https://www.thelibertybeacon.com/a-darpa-funded-implantable-biochip-to-detect-covid-19-could-hit-markets-by-2021


We’re doing a twofer on the hydrogel biosensor that may be used in an upcoming covid vaccine and very much more.

The second piece below, by Makia Freeman, was published on September 2 at her site. It explains the basics of what injectable, implantable hydrogel is and does. Freeman provides links to two short pieces on the work of the Silicon Valley Profusa company, which we recommend reading, although quite disturbing. See Early-Warning System for Detecting Infections Is Being Studied and Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality.

This is all rather technical. From our understanding of these two articles:

  1. The hydrogel biosensor functions like a platform inside the body that gets there by injection. It’s constructed of material that the body will not negatively react to, as happens with most materials implanted into the body, such as stents, replacement joints, breast implants, etc.

  2. The biosensor platform functions in different ways:

  3. As mentioned below in relation to the mRNA vaccine of Moderna, an engineered molecule to genetically reprogram our cells could be put into the body along with this biosensor platform via a vaccine/injection. (Which raises the question, what else does this ‘biochip’ platform come with?)

  4. Further, the platform contains sensors that perform a MONITORING function whereby many different biological processes are measured and recorded, including detecting if our body is fighting an infection before we become aware of it through symptoms (the company Profusa linked to Gates and Imperial College – has this technology already available to detect viral respiratory infections including Covid-19).

  5. The third function is to TRANSMIT THIS INFORMATION outside of our bodies via light-based digital signals to the IoT (internet of things via 5G).

  6. Would the receiving agent then have the capacity to remotely control what happens inside our bodies? If so, would this be simultaneous control over a population or could it be targeted to individuals or groups?

From Raul Diego’s piece, it seems that Moderna is going to lose ownership of its gene-altering vaccine in favour of the US government, who will have proprietary ownership of both the mRNA vaccine and the biosensor platform. Makia Freeman notes that the biosensor is likely to get FDA approval ‘around the same time we have been told to expect the rollout of the COVID vaccine’, early 2021.  

(For a great documentary on this issue where white collar crime expert David Martin exposes the MODeRNA fraudluent and criminal acts the led up to these developments, see our post at https://cv19news.wixsite.com/main/post/dr-david-e-martin-why-exposing-moderna-the-star-of-plandemic-indoctornation-reveals-the-truth).

Our motivation not to get vaccinated for anything should have just ramped up tenfold.


A DARPA-Funded Implantable Biochip To Detect COVID-19 Could Hit Markets By 2021


The most significant scientific discovery since gravity has been hiding in plain sight for nearly a decade and its destructive potential to humanity is so enormous that the biggest war machine on the planet immediately deployed its vast resources to possess and control it, financing its research and development through agencies like the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA) and HHS’ BARDA.

The revolutionary breakthrough came to a Canadian scientist named Derek Rossi in 2010 purely by accident. The now-retired Harvard professor claimed in an interview with the National Post that he found a way to “reprogram” the molecules that carry the genetic instructions for cell development in the human body, not to mention all biological lifeforms.

These molecules are called ‘messenger ribonucleic acid’ or mRNA and the newfound ability to rewrite those instructions to produce any kind of cell within a biological organism has radically changed the course of Western medicine and science, even if no one has really noticed yet. As Rossi, himself, puts it: “The real important discovery here was you could now use mRNA, and if you got it into the cells, then you could get the mRNA to express any protein in the cells, and this was the big thing.”

It was so big that by 2014, Rossi was able to retire after the company he co-founded with Flagship Pioneering private equity firm to exploit his innovation, – Moderna Inc., attracted almost a half billion dollars in federal award monies to begin developing vaccines using the technology. No longer affiliated with Moderna beyond his stock holdings, Rossi is just “watching for what happens next” and if he’s anything like the doting “hockey dad” he is portrayed to be, he must be horrified.

Remote control biology

As early as 2006, DARPA was already researching how to identify viral, upper respiratory pathogens through its Predicting Health and Disease (PHD) program, which led to the creation of the agency’s Biological Technologies Office (BTO), as reported by Whitney Webb in a May article for The Last American Vagabond. In 2014, DARPA’s BTO launched its “In Vivo Nanoplatforms” (IVN) program, which researches implantable nanotechnologies, leading to the development of ‘hydrogel’.

Hydrogel is a nanotechnology whose inventor early on boasted that “If [it] pans out, with approval from FDA, then consumers could get the sensors implanted in their core to measure their levels of glucose, oxygen, and lactate.” This contact lens-like material requires a special injector to be introduced under the skin where it can transmit light-based digital signals through a wireless network like 5G.

A penny aside a 3D printed hydrogel model of a lung-mimicking air sac in Rice University’s Houston BRC lab. Melissa Phillip | Houston Chronicle via AP

Once firmly implanted inside the body, human cells are at the mercy of any mRNA program delivered via this substrate, unleashing a nightmare of possibilities. It is, perhaps, the first true step towards full-on transhumanism; a “philosophy” that is in vogue with many powerful and influential people, such as Google’s Ray Kurzweil and Eric Schmidt and whose proponents see the fusion of technology and biology as an inevitable consequence of human progress.

The private company created to market this technology, that allows for biological processes to be controlled remotely and opens the door to the potential manipulation of our biological responses and, ultimately, our entire existence, is called Profusa Inc and its operations are funded with millions from NIH and DARPA. In March, the company was quietly inserted into the crowded COVID-19 bazaar in March 2020, when it announced an injectable biochip for the detection of viral respiratory diseases, including COVID-19.

A wholly-owned subsidiary

In July, a preliminary report funded by Fauci’s NIAID and the NIH on an mRNA Vaccine against SARS-CoV-2 was published in The New England Journal of Medicine, concluding that mRNA-1273 vaccine provided by Moderna for the study, “induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified,” and supported “further development of this vaccine.”

A month earlier, the NIH had claimed a joint stake in Moderna’s mRNA COVID-19 vaccine, citing a contract signed in December, 2019, stipulating that the “mRNA coronavirus vaccine candidates [are] developed and jointly owned” by both parties. Moderna disputes the federal government’s position, stating that the company “has a broad owned and licensed IP estate” and is “not aware of any IP that would prevent us from commercializing our product candidates, including mRNA-1273.”

A poster seeking volunteers to take part in a COVID-19 vaccine study by the NIH and Moderna Inc., July 27, 2020, in Binghamton, N.Y. Hans Pennink | AP

The only obstacle is a delivery system, which, though Moderna claims to be developing separately, is unlikely to get FDA approval before the federal government’s own DARPA-developed hydrogel technology, in tandem with Profusa’s DARPA-funded light sensor technology, which is expected to receive fast track authorization from the Food and Drug Administration by early 2021 and, more than likely, used to deploy a coronavirus vaccine with the capacity to literally change our DNA.

In addition, the Department of Health and Human Services (HHS), is currently investigating Moderna’s patent filings, claiming it failed to disclose “federal government support” in its COVID vaccine candidate patent applications, as required by law. The technicality could result in the federal government owning a 100 percent stake in mRNA-1273.

Original article


Hydrogel Biosensor: Implantable Nanotech to be Used in COVID Vaccines?


A hydrogel biosensor (a piece of implantable nanotech) may be used in an upcoming COVID vaccine to monitor your bodily activity – and more.

An implantable hydrogel biosensor, made via a DARPA-Gates funded Silicon Valley company, appears to be slated to be used in the upcoming COVID vaccine. The US Department of Defense and the Bill and Melinda Gates Foundation have partnered with Profusa, a Silicon Valley company, to develop a piece of nanotechnology made out of hydrogel (similar to a soft contact lens) that can be injected and implanted under the skin using a vaccine as a delivery system. This sensor (or more accurately a